Ideas to action: independent research for global prosperity
Coronavirus
More from the Series
Blog Post
March 26, 2021
Safe and efficacious vaccines are our best tools for defeating COVID-19. An unprecedented research and development effort has led to 12 vaccines with full or limited use emergency authorizations globally, but vaccinating everyone in the world as quickly as possible will require additional production...
CGD NOTES
March 26, 2021
Safe and efficacious vaccines are our best tools for defeating COVID-19, and an unprecedented research and development effort has led to 12 vaccines being approved for full, emergency, or limited use, globally. But to vaccinate the global population as quickly as possible requires additional product...
Blog Post
March 22, 2021
The Biden administration and the Congress rightly went big in the recently passed American Rescue Plan at a time of tremendous need. The package was appropriately focused on the domestic side, but it did not neglect the rest of the world. One might reasonably ask then why $1 billion or $2 billi...
Blog Post
March 15, 2021
In many low- and middle-income countries, the COVID-19 pandemic is limiting access to antenatal care and posing considerable challenges to global efforts to eliminate congenital syphilis. A review of the present WHO strategy to eliminate congenital syphilis is urgently neede...
Blog Post
March 08, 2021
As the virus spread and shut down life as we know it, global response became increasingly tainted by provincialism. From seizing masks and medical supplies en route to other countries to preventing vaccine exports, the world’s richest countries turned inward and neglected the global response effort....
Blog Post
March 04, 2021
In a recent blog, we asked “what do we really know about COVID-19’s impact on essential health services?” In that blog, our focus was primarily on what international partners were doing to monitor the effects of COVID-19 on essential health services. What we didn’t highlight is the increasingly deta...